Cin, D.; Soguksu, P.; Oren, M.M.; Ozgulnar, N.; Agacfidan, A.; Mese, S.
The Anti-SARS-CoV-2 S-Protein IgG, Which Is Detected Using the Chemiluminescence Microparticle Immunoassay (CMIA) in Individuals Having Either a History of COVID-19 Vaccination and/or SARS-CoV-2 Infection, Showed a High-Titer Neutralizing Effect. Viruses 2024, 16, 1409.
https://doi.org/10.3390/v16091409
AMA Style
Cin D, Soguksu P, Oren MM, Ozgulnar N, Agacfidan A, Mese S.
The Anti-SARS-CoV-2 S-Protein IgG, Which Is Detected Using the Chemiluminescence Microparticle Immunoassay (CMIA) in Individuals Having Either a History of COVID-19 Vaccination and/or SARS-CoV-2 Infection, Showed a High-Titer Neutralizing Effect. Viruses. 2024; 16(9):1409.
https://doi.org/10.3390/v16091409
Chicago/Turabian Style
Cin, Dilan, Pinar Soguksu, Meryem Merve Oren, Nuray Ozgulnar, Ali Agacfidan, and Sevim Mese.
2024. "The Anti-SARS-CoV-2 S-Protein IgG, Which Is Detected Using the Chemiluminescence Microparticle Immunoassay (CMIA) in Individuals Having Either a History of COVID-19 Vaccination and/or SARS-CoV-2 Infection, Showed a High-Titer Neutralizing Effect" Viruses 16, no. 9: 1409.
https://doi.org/10.3390/v16091409
APA Style
Cin, D., Soguksu, P., Oren, M. M., Ozgulnar, N., Agacfidan, A., & Mese, S.
(2024). The Anti-SARS-CoV-2 S-Protein IgG, Which Is Detected Using the Chemiluminescence Microparticle Immunoassay (CMIA) in Individuals Having Either a History of COVID-19 Vaccination and/or SARS-CoV-2 Infection, Showed a High-Titer Neutralizing Effect. Viruses, 16(9), 1409.
https://doi.org/10.3390/v16091409
